Regular blood tests can identify prostate cancer patients who are resistant to treatment

By | November 12, 2021
Regular blood tests before and during chemotherapy for prostate cancer can detect whether or not a patient is resistant or developing resistance to treatment with docetaxel, according to research presented at the NCRI Festival.